跳到正文
Nature Biotechnology·· 3 天前AI 评分25

成人及儿童胶质母细胞瘤类器官的冷冻保存技术及其对干细胞自我更新的影响

Cryopreservation techniques for adult and pediatric glioblastoma organoids and their effects on stem cell self-renewal

AI 导读

研究评估了多种自制与商业冷冻保存容器和培养基对大型基质胶胶质母细胞瘤(GBM)类器官及患者组织来源类器官干细胞自我更新的影响。含10% DMSO的常见非商业冷冻保存液(无血清或添加80% FBS)在维持GBM干细胞活力和自我更新方面不劣于甚至优于所测试的商业配方。冻存类器官复苏后仍保持活力、自我更新能力及组织学特征。

正文 · 原文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Organoids are advanced three-dimensional in vitro models that faithfully recapitulate tumor architecture, cellular heterogeneity, and microenvironmental interactions, making them valuable tools for cancer research, including for the lethal primary brain tumor glioblastoma (GBM). However, organoid generation is time- and resource-intensive, necessitating reliable cryopreservation techniques to enable long-term storage, biobanking, and sample sharing. Cryopreservation of small spheroids and organoids has been reported, but such methods have not been directly compared, and preservation of larger multi-millimeter-scale organoids has remained largely unexplored. Additionally, existing cryopreservation methods containing FBS, which induces differentiation in neural-lineage culture, have not been systematically benchmarked for their ability to maintain GBM self-renewal. We evaluated multiple custom-made and commercial cryopreservation containers and media on GBM self-renewal, as well as cell viability, structure, and stem cell preservation in large matrix-based GBM organoids and organoids directly from patient tissue. Common non-commercial cryopreservation media containing 10% DMSO, either serum-free or supplemented with 80% FBS, preserved GBM stem cell viability and self-renewal as well or better than commercial cryopreservation formulations tested. Cryopreserved organoids maintained post-thaw viability, self-renewal capacity, and histological characteristics following outgrowth. These findings demonstrate feasible methods to cryopreserve large GBM organoids, supporting their broader use in biobanking, collaborative studies, and experimental workflows.

Acknowledgements

We thank the Lathia lab at the Cleveland Clinic for providing patient-derived tumor cell culture samples utilized in this study.

Funding

This work was supported by the National Institute of Neurological Disorders and Stroke (R01NS126253 to C.G.H.), Worldwide Cancer Research (grant reference number 26–0094 to C.G.H.), the National Cancer Institute (Ruth L. Kirschstein National Research Service Award T32CA059366 to S.S.), and institutional funds from University Hospitals, Case Western Reserve University, and the Case Comprehensive Cancer Center (to C.G.H. and T.E.M.)

Author information

Authors and Affiliations

  1. Department of Biochemistry, Case Western Reserve University, Cleveland, OH, USA

    Sajina Shakya, Evan Joseph, Meghana A & Christopher G. Hubert

  2. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA

    Sajina Shakya, Evan Joseph, Tyler E. Miller & Christopher G. Hubert

  3. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA

    Prakriti Shukla & Christopher G. Hubert

  4. Department of Pathology, Case Western Reserve University, Cleveland, OH, USA

    Tempestt Nwachukwu, Shawn T. Ho & Tyler E. Miller

  5. Division of Genomic & Molecular Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

    Shawn T. Ho & Tyler E. Miller

Authors

  1. Sajina Shakya
  2. Evan Joseph
  3. Meghana A
  4. Prakriti Shukla
  5. Tempestt Nwachukwu
  6. Shawn T. Ho
  7. Tyler E. Miller
  8. Christopher G. Hubert

Corresponding author

Correspondence to Christopher G. Hubert.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shakya, S., Joseph, E., A, M. et al. Cryopreservation techniques for adult and pediatric glioblastoma organoids and their effects on stem cell self-renewal. Sci Rep (2026). https://doi.org/10.1038/s41598-026-77087-3

Download citation

  • Received: 08 June 2026

  • Accepted: 16 October 2026

  • Published: 26 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-77087-3

Keywords

来源:Nature Biotechnology · nature.com

AI 摘要声明:站内标题、摘要与推荐理由由模型基于公开来源生成,属机器生成内容,非原文;本页内容仅供医药行业信息参考,不构成医疗建议、诊断或用药依据。